|
[1]
|
Weller, M., Wick, W., Aldape, K., et al. (2015) Glioma. Nature Reviews. Disease Primers, 1, 15017. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Jiang, T., Nam, D.H., Ram, Z., et al. (2021) Clinical Practice Guidelines for the Management of Adult Diffuse Gliomas. Cancer Letters, 499, 60-72. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Stout, K.A., Dunn, A.R., Hoffman, C. and Miller, G.W. (2019) The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance. ACS Chemical Neuroscience, 10, 3927-3938. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Scranton, T.W., Iwata, M. and Carlson, S.S. (1993) The SV2 Protein of Synaptic Vesicles Is a Keratan Sulfate Proteoglycan. Journal of Neurochemistry, 61, 29-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Yao, J. and Bajjalieh, S.M. (2008) Synaptic Vesicle Pro-tein 2 Binds Adenine Nucleotides. The Journal of Biological Chemistry, 283, 20628-20634. [Google Scholar] [CrossRef]
|
|
[6]
|
Miyamoto, M., Kuzuya, A., Noda, Y., et al. (2020) Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1. Journal of Alzheimer’s Disease: JAD, 75, 173-185. [Google Scholar] [CrossRef]
|
|
[7]
|
Morgans, C.W., Kensel-Hammes, P., Hurley, J.B., et al. (2009) Loss of the Synaptic Vesicle Protein SV2B Results in Reduced Neurotransmission and Altered Synaptic Vesicle Protein Expres-sion in the Retina. PLOS ONE, 4, e5230. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fukusumi, Y., Wakamatsu, A., Takashima, N., Hasegawa, E., Miyauchi, N., Tomita, M. and Kawachi, H. (2015) SV2B Is Essential for the Integrity of the Glomerular Filtration Barrier. Laboratory Investigation; a Journal of Technical Methods and Pathology, 95, 534-545. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hao, N., Yang, D., Liu, T., Liu, S., Lu, X. and Chen, L. (2022) Laminin-Integrin a6b4 Interaction Activates Notch Signaling to Facilitate Bladder Cancer Development. BMC Cancer, 22, 558. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Liotta, L.A. (1986) Tumor Invasion and Metastases—Role of the Extracellular Matrix: Rhoads Memorial Award Lecture. Cancer Research, 46, 1-7.
|
|
[11]
|
Aumailley, M., Bruck-ner-Tuderman, L., Carter, W.G., et al. (2005) A Simplified Laminin Nomenclature. Matrix Biology: Journal of the Inter-national Society for Matrix Biology, 24, 326-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Iwamuro, M., Shiraha, H., Oyama, A., Uchida, D., Horiguchi, S. and Okada, H. (2021) Laminin-411 and -511 Modulate the Proliferation, Adhesion, and Morphology of Gastric Cancer Cells. Cell Biochemistry and Biophysics, 79, 407-418. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kunitomi, H., Kobayashi, Y., Wu, R.C., Takeda, T., Tominaga, E., Banno, K. and Aoki, D. (2020) LAMC1 Is a Prognostic Factor and a Potential Therapeutic Target in Endometrial Cancer. Journal of Gynecologic Oncology, 31, e11. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Vijayan, P., Hack, S., Yao, T., Qureshi, M.A., Paterson, A.D., John, R., Davenport, B., Lennon, R., Pei, Y. and Barua, M. (2021) LAMA2 and LOXL4 Are Candidate FSGS Genes. BMC Nephrology, 22, 320. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Liang, J., Li, H., Han, J., Jiang, J., Wang, J., Li, Y., Feng, Z., Zhao, R., Sun, Z., Lv, B. and Tian, H. (2020) Mex3a Interacts with LAMA2 to Promote Lung Adenocarcinoma Metasta-sis via PI3K/AKT Pathway. Cell Death & Disease, 11, 614. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Grenda, T., Grenda, A., Krawczyk, P. and Kwiatek, K. (2022) Botulinum Toxin in Cancer Therapy-Current Perspectives and Limitations. Applied Microbiology and Biotechnology, 106, 485-495. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Bandala, C., Miliar-García, A., Mejía-Barradas, C.M., Anaya-Ruiz, M., Luna-Arias, J.P., Bazán-Méndez, C.I., Gómez-López, M., Juárez-Méndez, S. and Lara-Padilla, E. (2012) Synaptic Vesicle Protein 2 (SV2) Isoforms. Asian Pacific Journal of Cancer Prevention: APJCP, 13, 5063-5067. [Google Scholar] [CrossRef]
|
|
[18]
|
Bandala, C., Cortés-Algara, A.L., Mejía-Barradas, C.M., Ilizaliturri-Flores, I., Dominguez-Rubio, R., Bazán-Méndez, C.I., Floriano-Sánchez, E., Luna-Arias, J.P., Anaya-Ruiz, M. and Lara-Padilla, E. (2015) Botulinum Neurotoxin Type A Inhibits Synaptic Vesicle 2 Expression in Breast Cancer Cell Lines. International Journal of Clinical and Experimental Pathology, 8, 8411-8418.
|
|
[19]
|
Chiu, Y.C., Wang, L.J., Lu, T.P., Hsiao, T.H., Chuang, E.Y. and Chen, Y. (2017) Differential Correlation Analysis of Glioblastoma Reveals Immune ceRNA Interactions Predictive of Patient Survival. BMC Bioinformatics, 18, 132. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, H., Liu, D. and Yang, J. (2019) Prognostic Risk Model Construction and Molecular Marker Identification in Glioblastoma Multiforme Based on mRNA/microRNA/Long Non-Coding RNA Analysis Using Random Survival Forest Method. Neoplasma, 66, 459-469. [Google Scholar] [CrossRef]
|
|
[21]
|
Zhang, X., Sun, Y., Wang, P., Yang, C. and Li, S. (2017) Exploration of the Molecular Mechanism of Prostate Cancer Based on mRNA and miRNA Expression Profiles. Onco-Targets and Therapy, 10, 3225-3232. [Google Scholar] [CrossRef]
|
|
[22]
|
Clegg, N., Ferguson, C., True, L.D., Arnold, H., Moorman, A., Quinn, J.E., Vessella, R.L. and Nelson, P.S. (2003) Molecular Characterization of Prostatic Small-Cell Neuroendocrine Carci-noma. The Prostate, 55, 55-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Iezzi, M., Theander, S., Janz, R., Loze, C. and Wollheim, C.B. (2005) SV2A and SV2C Are Not Vesicular Ca2+ Transporters but Control Glucose-Evoked Granule Recruitment. Journal of Cell Science, 118, 5647-5660. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Karsenty, G., Rocha, J., Chevalier, S., Scarlata, E., Andrieu, C., Zouanat, F.Z., Rocchi, P., Giusiano, S., Elzayat, E.A. and Corcos, J. (2009) Botulinum Toxin Type A Inhibits the Growth of LNCaP Human Prostate Cancer Cells in Vitro and in Vivo. The Prostate, 69, 1143-1150. [Google Scholar] [CrossRef] [PubMed]
|